Loading…
Use of niosomes for the treatment of intracellular pathogens infecting the lungs
The delivery of drugs in an encapsulated environment is designed to precisely target specific tissues, avoiding a systemic circulation of the drug. Lungs are organs exposed to the environment with multiple defense barriers. However, many pathogens can still colonize and infect the airways bypassing...
Saved in:
Published in: | Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2023-07, Vol.15 (4), p.e1891-n/a |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193 |
---|---|
cites | cdi_FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193 |
container_end_page | n/a |
container_issue | 4 |
container_start_page | e1891 |
container_title | Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology |
container_volume | 15 |
creator | Bach, Horacio Lorenzo‐Leal, Ana C. |
description | The delivery of drugs in an encapsulated environment is designed to precisely target specific tissues, avoiding a systemic circulation of the drug. Lungs are organs exposed to the environment with multiple defense barriers. However, many pathogens can still colonize and infect the airways bypassing the hostile environment of the lungs. In more complicated situations, some pathogens have developed strategies to multiply and survive within macrophages, one of the first immune cell responses to clearing infections in mammals. Niosomes are artificial vesicles that can be loaded with drugs, offering an alternative strategy to treat intracellular pathogens as nanocarriers. Members of the mycobacteria genus are intracellular pathogens that have evolved to escape the immunological response, specifically in macrophages, the white cells responsible for the clearance of pathogens. This review analyzed the state‐of‐the‐art niosome synthesis aimed at tackling the problem of intracellular pathogen therapy.
This article is categorized under:
Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease
Nanotechnology Approaches to Biology > Nanoscale Systems in Biology
Macrophage–niosome fusion. The composition of the bilayers of the niosome allows a fast fusion with the macrophage membrane cells. The antibiotics loaded in the niosomes (red triangles) are released into the macrophage upon fusion. Created using BioRender.com (2022, https://app.biorender.com). |
doi_str_mv | 10.1002/wnan.1891 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2799170963</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2836192043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193</originalsourceid><addsrcrecordid>eNp1kE1PwkAQhjdGI4ge_AOmiRc9FPar7e6REL8Sgh4kHjdLnUJJu4u72xD-vS2gBxNPM5l55s07L0LXBA8JxnS0NdoMiZDkBPWJZDLGmJPTY58QkvbQhfdrjFOe0uQc9ViGGU0x7aO3uYfIFpEprbc1-KiwLgoriIIDHWowoduWJjidQ1U1lXbRRoeVXYLx7byAPJRmuT-pGrP0l-is0JWHq2MdoPnjw_vkOZ6-Pr1MxtM4Z0KQOC-A61QKSTnmIAuda840EZAyojMiWq9YU7bgLKGMMpA5FjrBCyJ4LnT72ADdHXQ3zn414IOqS99Z1AZs4xXNpCQZlilr0ds_6No2zrTuFBUsJZJi3lH3Byp31nsHhdq4stZupwhWXcyqi1l1MbfszVGxWdTw-Uv-5NoCowOwLSvY_a-kPmbj2V7yG8rFhgQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2836192043</pqid></control><display><type>article</type><title>Use of niosomes for the treatment of intracellular pathogens infecting the lungs</title><source>Wiley</source><creator>Bach, Horacio ; Lorenzo‐Leal, Ana C.</creator><creatorcontrib>Bach, Horacio ; Lorenzo‐Leal, Ana C.</creatorcontrib><description>The delivery of drugs in an encapsulated environment is designed to precisely target specific tissues, avoiding a systemic circulation of the drug. Lungs are organs exposed to the environment with multiple defense barriers. However, many pathogens can still colonize and infect the airways bypassing the hostile environment of the lungs. In more complicated situations, some pathogens have developed strategies to multiply and survive within macrophages, one of the first immune cell responses to clearing infections in mammals. Niosomes are artificial vesicles that can be loaded with drugs, offering an alternative strategy to treat intracellular pathogens as nanocarriers. Members of the mycobacteria genus are intracellular pathogens that have evolved to escape the immunological response, specifically in macrophages, the white cells responsible for the clearance of pathogens. This review analyzed the state‐of‐the‐art niosome synthesis aimed at tackling the problem of intracellular pathogen therapy.
This article is categorized under:
Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease
Nanotechnology Approaches to Biology > Nanoscale Systems in Biology
Macrophage–niosome fusion. The composition of the bilayers of the niosome allows a fast fusion with the macrophage membrane cells. The antibiotics loaded in the niosomes (red triangles) are released into the macrophage upon fusion. Created using BioRender.com (2022, https://app.biorender.com).</description><identifier>ISSN: 1939-5116</identifier><identifier>EISSN: 1939-0041</identifier><identifier>DOI: 10.1002/wnan.1891</identifier><identifier>PMID: 37032602</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Animals ; Biology ; Drug delivery ; Drug Delivery Systems ; Drugs ; Immune clearance ; Immune response ; Immune system ; Immunology ; Immunosuppressive agents ; Intracellular ; intracellular pathogens ; Leukocytes ; Liposomes ; Lung ; lung infection ; Lungs ; Macrophages ; Mammals ; mycobacteria ; nanocarriers ; Nanomedicine ; Nanotechnology ; niosomes ; Pathogens</subject><ispartof>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2023-07, Vol.15 (4), p.e1891-n/a</ispartof><rights>2023 The Authors. published by Wiley Periodicals LLC.</rights><rights>2023 The Authors. WIREs Nanomedicine and Nanobiotechnology published by Wiley Periodicals LLC.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193</citedby><cites>FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193</cites><orcidid>0000-0002-7740-9299</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37032602$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bach, Horacio</creatorcontrib><creatorcontrib>Lorenzo‐Leal, Ana C.</creatorcontrib><title>Use of niosomes for the treatment of intracellular pathogens infecting the lungs</title><title>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology</title><addtitle>Wiley Interdiscip Rev Nanomed Nanobiotechnol</addtitle><description>The delivery of drugs in an encapsulated environment is designed to precisely target specific tissues, avoiding a systemic circulation of the drug. Lungs are organs exposed to the environment with multiple defense barriers. However, many pathogens can still colonize and infect the airways bypassing the hostile environment of the lungs. In more complicated situations, some pathogens have developed strategies to multiply and survive within macrophages, one of the first immune cell responses to clearing infections in mammals. Niosomes are artificial vesicles that can be loaded with drugs, offering an alternative strategy to treat intracellular pathogens as nanocarriers. Members of the mycobacteria genus are intracellular pathogens that have evolved to escape the immunological response, specifically in macrophages, the white cells responsible for the clearance of pathogens. This review analyzed the state‐of‐the‐art niosome synthesis aimed at tackling the problem of intracellular pathogen therapy.
This article is categorized under:
Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease
Nanotechnology Approaches to Biology > Nanoscale Systems in Biology
Macrophage–niosome fusion. The composition of the bilayers of the niosome allows a fast fusion with the macrophage membrane cells. The antibiotics loaded in the niosomes (red triangles) are released into the macrophage upon fusion. Created using BioRender.com (2022, https://app.biorender.com).</description><subject>Animals</subject><subject>Biology</subject><subject>Drug delivery</subject><subject>Drug Delivery Systems</subject><subject>Drugs</subject><subject>Immune clearance</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunology</subject><subject>Immunosuppressive agents</subject><subject>Intracellular</subject><subject>intracellular pathogens</subject><subject>Leukocytes</subject><subject>Liposomes</subject><subject>Lung</subject><subject>lung infection</subject><subject>Lungs</subject><subject>Macrophages</subject><subject>Mammals</subject><subject>mycobacteria</subject><subject>nanocarriers</subject><subject>Nanomedicine</subject><subject>Nanotechnology</subject><subject>niosomes</subject><subject>Pathogens</subject><issn>1939-5116</issn><issn>1939-0041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kE1PwkAQhjdGI4ge_AOmiRc9FPar7e6REL8Sgh4kHjdLnUJJu4u72xD-vS2gBxNPM5l55s07L0LXBA8JxnS0NdoMiZDkBPWJZDLGmJPTY58QkvbQhfdrjFOe0uQc9ViGGU0x7aO3uYfIFpEprbc1-KiwLgoriIIDHWowoduWJjidQ1U1lXbRRoeVXYLx7byAPJRmuT-pGrP0l-is0JWHq2MdoPnjw_vkOZ6-Pr1MxtM4Z0KQOC-A61QKSTnmIAuda840EZAyojMiWq9YU7bgLKGMMpA5FjrBCyJ4LnT72ADdHXQ3zn414IOqS99Z1AZs4xXNpCQZlilr0ds_6No2zrTuFBUsJZJi3lH3Byp31nsHhdq4stZupwhWXcyqi1l1MbfszVGxWdTw-Uv-5NoCowOwLSvY_a-kPmbj2V7yG8rFhgQ</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Bach, Horacio</creator><creator>Lorenzo‐Leal, Ana C.</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7740-9299</orcidid></search><sort><creationdate>202307</creationdate><title>Use of niosomes for the treatment of intracellular pathogens infecting the lungs</title><author>Bach, Horacio ; Lorenzo‐Leal, Ana C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Biology</topic><topic>Drug delivery</topic><topic>Drug Delivery Systems</topic><topic>Drugs</topic><topic>Immune clearance</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunology</topic><topic>Immunosuppressive agents</topic><topic>Intracellular</topic><topic>intracellular pathogens</topic><topic>Leukocytes</topic><topic>Liposomes</topic><topic>Lung</topic><topic>lung infection</topic><topic>Lungs</topic><topic>Macrophages</topic><topic>Mammals</topic><topic>mycobacteria</topic><topic>nanocarriers</topic><topic>Nanomedicine</topic><topic>Nanotechnology</topic><topic>niosomes</topic><topic>Pathogens</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bach, Horacio</creatorcontrib><creatorcontrib>Lorenzo‐Leal, Ana C.</creatorcontrib><collection>Wiley-Blackwell Open Access Titles (Open Access)</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bach, Horacio</au><au>Lorenzo‐Leal, Ana C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of niosomes for the treatment of intracellular pathogens infecting the lungs</atitle><jtitle>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology</jtitle><addtitle>Wiley Interdiscip Rev Nanomed Nanobiotechnol</addtitle><date>2023-07</date><risdate>2023</risdate><volume>15</volume><issue>4</issue><spage>e1891</spage><epage>n/a</epage><pages>e1891-n/a</pages><issn>1939-5116</issn><eissn>1939-0041</eissn><abstract>The delivery of drugs in an encapsulated environment is designed to precisely target specific tissues, avoiding a systemic circulation of the drug. Lungs are organs exposed to the environment with multiple defense barriers. However, many pathogens can still colonize and infect the airways bypassing the hostile environment of the lungs. In more complicated situations, some pathogens have developed strategies to multiply and survive within macrophages, one of the first immune cell responses to clearing infections in mammals. Niosomes are artificial vesicles that can be loaded with drugs, offering an alternative strategy to treat intracellular pathogens as nanocarriers. Members of the mycobacteria genus are intracellular pathogens that have evolved to escape the immunological response, specifically in macrophages, the white cells responsible for the clearance of pathogens. This review analyzed the state‐of‐the‐art niosome synthesis aimed at tackling the problem of intracellular pathogen therapy.
This article is categorized under:
Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease
Nanotechnology Approaches to Biology > Nanoscale Systems in Biology
Macrophage–niosome fusion. The composition of the bilayers of the niosome allows a fast fusion with the macrophage membrane cells. The antibiotics loaded in the niosomes (red triangles) are released into the macrophage upon fusion. Created using BioRender.com (2022, https://app.biorender.com).</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>37032602</pmid><doi>10.1002/wnan.1891</doi><tpages>21</tpages><orcidid>https://orcid.org/0000-0002-7740-9299</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1939-5116 |
ispartof | Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2023-07, Vol.15 (4), p.e1891-n/a |
issn | 1939-5116 1939-0041 |
language | eng |
recordid | cdi_proquest_miscellaneous_2799170963 |
source | Wiley |
subjects | Animals Biology Drug delivery Drug Delivery Systems Drugs Immune clearance Immune response Immune system Immunology Immunosuppressive agents Intracellular intracellular pathogens Leukocytes Liposomes Lung lung infection Lungs Macrophages Mammals mycobacteria nanocarriers Nanomedicine Nanotechnology niosomes Pathogens |
title | Use of niosomes for the treatment of intracellular pathogens infecting the lungs |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T15%3A25%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20niosomes%20for%20the%20treatment%20of%20intracellular%20pathogens%20infecting%20the%20lungs&rft.jtitle=Wiley%20interdisciplinary%20reviews.%20Nanomedicine%20and%20nanobiotechnology&rft.au=Bach,%20Horacio&rft.date=2023-07&rft.volume=15&rft.issue=4&rft.spage=e1891&rft.epage=n/a&rft.pages=e1891-n/a&rft.issn=1939-5116&rft.eissn=1939-0041&rft_id=info:doi/10.1002/wnan.1891&rft_dat=%3Cproquest_cross%3E2836192043%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3881-cfe4a69892404e9faca43a18e631a7180060a23b4352323e9c08a50b184c8a193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2836192043&rft_id=info:pmid/37032602&rfr_iscdi=true |